- Home
- NGEN vs NAUT Comparison
NGEN vs NAUT Comparison
Compare NGEN & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NGEN | NAUT |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | Canada | United States |
| Employees | 9 | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 197.5M | 218.6M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | NGEN | NAUT |
|---|---|---|
| Price | $1.61 | $1.05 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $18.00 | $4.00 |
| AVG Volume (30 Days) | 739.3K | ★ 885.4K |
| Earning Date | 04-02-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 16.07 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $992.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.59 | $0.62 |
| 52 Week High | $5.93 | $4.31 |
Technical Indicators
Market Signals| Indicator | NGEN | NAUT |
|---|---|---|
| Relative Strength Index (RSI) | 32.53 | 22.52 |
| Support Level | N/A | N/A |
| Resistance Level | $2.22 | $1.57 |
| Average True Range (ATR) | 0.11 | 0.14 |
| MACD | 0.01 | -0.03 |
| Stochastic Oscillator | 2.32 | 4.17 |
Price Performance
Historical ComparisonAbout NGEN NervGen Pharma Corp. Common stock
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.
About NAUT Nautilus Biotechnolgy Inc.
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.